Strides Arcolab shares up 4% on Sun Pharma deal
Shares of Strides Arcolab rose by 4 percent Monday as it entered into a pact with Sun Pharma to buy from it erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India for Rs 165 crore.
Sep 21, 2015, 13:27 PM IST
Sun Pharma to sell Ranbaxy's 2 CNS divisions to Strides for Rs 165 crore
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.
Sep 19, 2015, 15:13 PM IST
Strides Arcolab seeks shareholder nod for Rs 2k cr outlay
The approval of shareholders is sought through a postal ballot. The e-voting will commence on June 10 and end on July 9, the company said in a filing to BSE.
Jun 10, 2015, 17:55 PM IST
Strides Arcolab reports Q4 net profit at Rs 69.66 cr
Strides Arcolab shares were trading 0.60 percent down at Rs 1,180.80 per scrip during afternoon session on the BSE.
May 22, 2015, 15:31 PM IST
Strides buys Aspen's Australia drug assets for A$380 mn
Strides Arcolab on Thursday said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for about Rs 1,910 crore.
May 21, 2015, 14:46 PM IST
